Defining the Functional Role of Iron in Aerobic Training and Physical Performance
Defining the Functional and Metabolic Role of Iron in Aerobic Training and Physical Performance
1 other identifier
interventional
109
1 country
1
Brief Summary
Iron deficiency is known to negatively impact physical performance, attention, and time spent doing physical activity. As a result, an iron deficient person must expend more energy to complete the same amount of work as someone who is healthy. Another interesting relationship has been observed between exercise training and iron status in that women who participate in exercise training often have higher rates of iron deficiency than sedentary women. ID is commonly treated using daily iron supplementation. However, it is currently unknown whether participating in regular exercise somehow impacts the effectiveness of iron supplementation. Iron deficient women who participate in exercise programs may potentially benefit less from iron supplementation than those who do not. Another common treatment for the symptoms of iron deficiency is the traditional Chinese herbal treatment, Ba-Zhen-Ke-Li (BZKL). While studies have shown that BZKL impacts expression of some iron-related proteins and increases endurance performance in rats, no studies have examined the efficacy of BZKL in improving iron markers or physical performance in humans. This study will compare the efficacy of BZKL in improving iron status and physical performance with that of ferrous sulfate supplementation. The Cornell research team will achieve these objectives in collaboration with colleagues at Kunming Medical University (KMU) in Kunming, China. A double-blind, randomized, placebo controlled study will be conducted by a Cornell graduate student at KMU. The subjects will be healthy women, age 18-26 years, attending KMU. Blood samples will be collected and analyzed for measures of iron). Subjects will be randomly assigned to receive 50 mg of ferrous sulfate (10 mg of elemental iron), 6mg of BZKL, or an identical placebo pill twice daily for 8 weeks. Subjects will be further randomly sub-divided to receive aerobic exercise training or no training during the 8-week supplementation period. At weeks 4 and 8, subjects will perform the same series of tests as was performed at baseline. The investigators hypothesize that: 1. the women who train and received iron will have smaller improvements in iron status than those who do not train 2. The women who receive iron and train will have greater improvements in physical performance than those who train and do not receive iron, and 3. The women who receive BZKL will improve their iron status or physical performance more than those who receive placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 14, 2016
CompletedFirst Posted
Study publicly available on registry
December 23, 2016
CompletedDecember 23, 2016
December 1, 2016
10 months
December 14, 2016
December 20, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Concentration of serum ferritin in µg/L
Changes from week 0 to weeks 4 and 8 measured both within and between groups.
Change in concentration of the 5 biomarkers from weeks 0 to 8. Change in concentration of the 5 biomarkers from weeks 0 to 4.
Concentration of soluble transferrin receptor in mg/L
Changes from week 0 to weeks 4 and 8 measured both within and between groups.
Change in concentration of the 5 biomarkers from weeks 0 to 8. Change in concentration of the 5 biomarkers from weeks 0 to 4.
Concentration of hemoglobin g/L
Changes from week 0 to weeks 4 and 8 measured both within and between groups.
Change in concentration of the 5 biomarkers from weeks 0 to 8. Change in concentration of the 5 biomarkers from weeks 0 to 4.
Concentration of alpha-1-acid glycoprotein in g/L
Changes from week 0 to weeks 4 and 8 measured both within and between groups.
Change in concentration of the 5 biomarkers from weeks 0 to 8. Change in concentration of the 5 biomarkers from weeks 0 to 4.
Concentration of C-reactive protein in mg/L
Changes from week 0 to weeks 4 and 8 measured both within and between groups.
Change in concentration of the 5 biomarkers from weeks 0 to 8. Change in concentration of the 5 biomarkers from weeks 0 to 4.
Secondary Outcomes (2)
Human performance as assessed by maximal capacity for oxygen uptake (mL/min/kg body weight)
Change from weeks 0 to 8. Change from weeks 0 to 4.
Human performance as assessed by energetic efficiency (in %)
Change from weeks 0 to 8. Change from weeks 0 to 4.
Study Arms (6)
Iron trained
EXPERIMENTALIron Untrained
EXPERIMENTALBZKL Trained
EXPERIMENTALBZKL Untrained
EXPERIMENTALPlacebo Trained
EXPERIMENTALPlacebo Untrained
PLACEBO COMPARATORInterventions
1. Ferrous sulfate: 100 mg/day of FeSO4 dosed in 2 capsules taken individually by mouth with breakfast and dinner. Capsules were made with FeSO4 and dextrose. Analysis has shown that each capsule contains 11mg of elemental iron, which is expected to be absorbed at roughly 33% bioavailability. 2. Aerobic Training: 25 minutes/day, 5 days/week for 8 weeks working at an intensity between 75-85% of age-predicted maximum heart rate.
1\. Ferrous sulfate: 100 mg/day of FeSO4 dosed in 2 capsules taken individually by mouth with breakfast and dinner. Capsules were made with FeSO4 and dextrose. Analysis has shown that each capsule contains 11mg of elemental iron, which is expected to be absorbed at roughly 33% bioavailability.
1. BaZhen KeLi capsules: Traditional Chinese herbal supplement composed of: Radix Paeoniae Alba (White peony root), Rhizoma Atractylodis (Atractylodes), Rhizoma Chuanxiong (Chuanxiong), Radix Angelicae Sinensis (Angelica), Radix Codonopsis Pilosula (Codonopsis), Poria cocos (Poria), licorice, and Rehmannia glutinosa Each pill contained 5g of licorice and 10g of all other ingredients. Dosed in 2 capsules taken individually by mouth with breakfast and dinner. Analysis has shown that each capsule contained 0.5mg of elemental iron. 2. Aerobic Training: 25 minutes/day, 5 days/week for 8 weeks working at an intensity between 75-85% of age-predicted maximum heart rate.
1\. BaZhen KeLi capsules: Traditional Chinese herbal supplement composed of: Radix Paeoniae Alba (White peony root), Rhizoma Atractylodis (Atractylodes), Rhizoma Chuanxiong (Chuanxiong), Radix Angelicae Sinensis (Angelica), Radix Codonopsis Pilosula (Codonopsis), Poria cocos (Poria), licorice, and Rehmannia glutinosa Each pill contained 5g of licorice and 10g of all other ingredients. Dosed in 2 capsules taken individually by mouth with breakfast and dinner. Analysis has shown that each capsule contained 0.5mg of elemental iron.
1\. Aerobic Training: 25 minutes/day, 5 days/week for 8 weeks working at an intensity between 75-85% of age-predicted maximum heart rate.
Eligibility Criteria
You may qualify if:
- Age 18-26
- Must be able to complete exercise on a stationary bicycle
- Clinical diagnosis of iron depletion without severe anemia (sFer\< 25µg/L, Hb\>110g/L)
- Willing to comply with the 8-week supplementation and if assigned, training program
You may not qualify if:
- age less than 18
- severe anemia (Hb\<90g/L in blood analyses)
- current pregnancy or pregnancy within the previous year
- recent infectious illness or fever
- current inflammation or chronic inflammatory diseases (AGP \> 1.0 g/L in blood analyses)
- hemolytic anemia
- chronic respiratory disease
- musculoskeletal problems
- history of eating disorders
- smoking, BMI \< 18 or \>24 kg/m2
- consumption of medications that may affect dietary iron intake or absorption or that have anticoagulant properties
- participation in varsity sports team
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kunming Medical University, Department of Nursing,
Longcheng, Yunnan, China
Related Publications (2)
Pompano LM, Haas JD. Increasing Iron Status through Dietary Supplementation in Iron-Depleted, Sedentary Women Increases Endurance Performance at Both Near-Maximal and Submaximal Exercise Intensities. J Nutr. 2019 Feb 1;149(2):231-239. doi: 10.1093/jn/nxy271.
PMID: 30649365DERIVEDPompano LM, Haas JD. Efficacy of iron supplementation may be misinterpreted using conventional measures of iron status in iron-depleted, nonanemic women undergoing aerobic exercise training. Am J Clin Nutr. 2017 Dec;106(6):1529-1538. doi: 10.3945/ajcn.117.152777. Epub 2017 Nov 1.
PMID: 29092885DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jere Haas, PhD
Cornell University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 14, 2016
First Posted
December 23, 2016
Study Start
August 1, 2014
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
December 23, 2016
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will not share